Clinical Trial Update: Ozurdex for Treatment of Recalcitrant Diabetic Macular Edema [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating Ozurdex (dexamethasone implant) for treatment of recalcitrant diabetic macular edema has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema
• Non-proliferative Diabetic Retinopathy
• Proliferative Diabetic Retinopathy

Drugs mentioned

• Ozurdex (dexamethasone intravitreal implant)

Snippet

Sponsor: Retina Macula Institute | Conditions: Diabetic Macular Edema, Non-proliferative Diabetic Retinopathy | Phase 2 | Status: COMPLETED | Results posted: 2017-05-31